ID: ALA2057224

Max Phase: Preclinical

Molecular Formula: C19H31NO3

Molecular Weight: 321.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(=O)OCCCCCCCCCCCOc1ccccn1

Standard InChI:  InChI=1S/C19H31NO3/c1-2-19(21)23-17-13-9-7-5-3-4-6-8-12-16-22-18-14-10-11-15-20-18/h10-11,14-15H,2-9,12-13,16-17H2,1H3

Standard InChI Key:  AHZVOBBDIWMAHX-UHFFFAOYSA-N

Associated Targets(non-human)

Leishmania mexicana 936 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 321.46Molecular Weight (Monoisotopic): 321.2304AlogP: 4.92#Rotatable Bonds: 14
Polar Surface Area: 48.42Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.92CX LogP: 5.33CX LogD: 5.33
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.36Np Likeness Score: -0.66

References

1. García Liñares G, Parraud G, Labriola C, Baldessari A..  (2012)  Chemoenzymatic synthesis and biological evaluation of 2- and 3-hydroxypyridine derivatives against Leishmania mexicana.,  20  (15): [PMID:22781310] [10.1016/j.bmc.2012.06.028]

Source